Literature DB >> 18067173

Association of olfactory dysfunction with risk for future Parkinson's disease.

G Webster Ross1, Helen Petrovitch, Robert D Abbott, Caroline M Tanner, Jordan Popper, Kamal Masaki, Lenore Launer, Lon R White.   

Abstract

OBJECTIVE: Although olfactory dysfunction is commonly associated with Parkinson's disease (PD), it is not known whether such dysfunction can predate the onset of clinical PD in a community-based population. This study examines the association of olfactory dysfunction with future development of PD in Honolulu-Asia Aging Study cohort members
METHODS: Olfaction was assessed from 1991 to 1996 in 2,267 men in the Honolulu-Asia Aging Study aged 71 to 95 years who were free of clinical PD and dementia at the time of olfaction testing. Participants were followed for up to 8 years for incident PD
RESULTS: In the course of follow-up, 35 men were diagnosed with PD (24.6/10,000 person-years). The average age at the time of diagnosis was 82.9 +/- 3.8 (range, 76-93) years, and the average time to a diagnosis was 4.0 +/- 1.9 (range, 1-8) years. During the first 4 years of follow-up, age-adjusted incidence of PD declined from 54.5/10,000 person-years in the lowest quartile of odor identification to 26.6, 8.2, and 8.4/10,000 person-years in the second, third, and fourth quartiles, respectively (p < 0.001 for trend). After adjustment for age and other potential confounders, the odds ratios for PD in the lowest quartile was 5.2 (95% confidence interval, 1.5-25.6) compared with the top two quartiles. This relation was not evident beyond 4 years of follow-up.
INTERPRETATION: Impaired olfaction can predate clinical PD in men by at least 4 years and may be a useful screening tool to detect those at high risk for development of PD in later life.

Entities:  

Mesh:

Year:  2008        PMID: 18067173     DOI: 10.1002/ana.21291

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  211 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 2.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

3.  Premotor Parkinson's disease: concepts and definitions.

Authors:  Andrew Siderowf; Anthony E Lang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

4.  A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Authors:  Sheila M Fleming; Caitlin K Mulligan; Franziska Richter; Farzad Mortazavi; Vincent Lemesre; Carmen Frias; Chunni Zhu; Alistair Stewart; Illana Gozes; Bruce Morimoto; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2010-12-27       Impact factor: 4.314

5.  Odor identification and mortality in old age.

Authors:  Robert S Wilson; Lei Yu; David A Bennett
Journal:  Chem Senses       Date:  2010-10-05       Impact factor: 3.160

Review 6.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

7.  Advanced time-series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson's disease patients.

Authors:  Sanne Boesveldt; Cornelis J Stam; Dirk L Knol; Jeroen P A Verbunt; Henk W Berendse
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 8.  Dual-transmitter neurons: functional implications of co-release and co-transmission.

Authors:  Christopher E Vaaga; Maria Borisovska; Gary L Westbrook
Journal:  Curr Opin Neurobiol       Date:  2014-05-13       Impact factor: 6.627

9.  Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.

Authors:  Ming Cao; Zhu-Qin Gu; Yuan Li; Hui Zhang; Xiao-Juan Dan; Shan-Shan Cen; Da-Wei Li; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

10.  Fine particulate matter exposure and olfactory dysfunction among urban-dwelling older US adults.

Authors:  Gaurav S Ajmani; Helen H Suh; Kristen E Wroblewski; David W Kern; L Philip Schumm; Martha K McClintock; Jeff D Yanosky; Jayant M Pinto
Journal:  Environ Res       Date:  2016-09-29       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.